Related Experiment Video

Updated: Jul 10, 2026

An Investigation of the Effects of Sports-related Concussion in Youth Using Functional Magnetic Resonance Imaging and the Head Impact Telemetry System
07:02

An Investigation of the Effects of Sports-related Concussion in Youth Using Functional Magnetic Resonance Imaging and the Head Impact Telemetry System

Published on: January 12, 2011

Pediatric headache: an examination of process variables in treatment

Jamie A Cvengros1, Dennis Harper, Michael Shevell

  • 1University of Iowa, Iowa City, IA 52242, USA. jamie-cvengros@uiowa.edu

Journal of Child Neurology
|October 18, 2007
PubMed

Insights

Behavioral treatments show promise for childhood headache, but factors like child demographics and treatment duration may influence effectiveness. Further research is needed to optimize interventions for pediatric headache management.

Area of Science:

  • Pediatric Neurology
  • Behavioral Psychology
  • Evidence-Based Medicine

Background:

  • Childhood headache is a prevalent condition requiring effective treatment strategies.
  • Behavioral and psychological interventions are increasingly utilized for pediatric headache.
  • Understanding factors influencing treatment efficacy is crucial for optimizing care.

Purpose of the Study:

  • To conduct a systematic review of studies on childhood headache treatment efficacy.
  • To examine process variables associated with behavioral and psychological treatments for pediatric headache.
  • To identify factors that may moderate treatment outcomes in children under 12.

Main Methods:

  • Systematic literature search of Medline database (1966-2005).
  • Inclusion criteria focused on studies evaluating treatment efficacy for headache in children younger than 12.
  • Analysis of 9 selected studies to identify relevant process and treatment variables.

Main Results:

  • Evidence supports the efficacy of behavioral treatments for childhood headache.
  • Child demographics and treatment characteristics (e.g., duration) may influence treatment effectiveness.
  • Specific process variables require further investigation to understand their moderating role.

Conclusions:

  • Behavioral interventions are a viable option for treating headaches in young children.
  • Individual patient factors and treatment parameters are important considerations for optimizing outcomes.
  • Further research should explore these moderating variables to refine treatment protocols for pediatric headache.

More Related Videos

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...